As such, these data indicate that we were able to successfully establish a PPAR-related HCC prognostic model in which MMP1, HMGCS2, and SLC27A5 serve as effective predictors of HCC patient outcomes. This evidence concerns the gene PPARA and hepatocellular carcinoma.